Precision for Medicine Receives Multiple CRO Awards
Precision for Medicine, a leading biomarker-driven clinical research organization (CRO), received wide recognition at the prestigious 2023 CRO Leadership Awards. The awards acknowledge top CRO partners and are determined by feedback from pharma and biotech sponsors. Precision has been honored in all five categories: Capabilities, Compatibility, Expertise, Quality, and Reliability, securing awards in the Overall, Big Pharma, and Small Pharma categories, along with several distinguished Champion Awards.
This recognition serves as a testament to our commitment to quality and our clients’ trust in delivering measurable results.
Event: Cell & Gene Reception @ BIO, 2023
Precision is honored to be a co-host of this year’s ARM Cell & Gene Reception @ BIO, May 5, 2023, in Boston, MA. Attendees will enjoy extensive networking opportunities with the sector’s top decision makers including executives from leading companies located in the Boston area!
Connect with our Advanced Therapy experts!
- Date: Monday, June 5, 2023
- Time: 6:00pm – 9:00pm ET
- Location: Woods Hill Pier 4, Boston, MA
Registration is complimentary – CLICK HERE to reserve your spot.
Conference: ASGCT, 2023
Precision will be at this year’s ASGCT, May 16-20, 2023, in Los Angeles, CA. Connect with our team of experts as they lead meaningful presentations and discussions throughout this event providing insights into the development for cell and gene therapies.
Connect with our Advanced Therapy experts!
- Visit us at booth 754 in the exhibition area
- Be sure to attend Precision’s own, Travis Harrison’s presentation on May 19, 2023, at 4:45PM PDT – 5:15PM PDT
You can register for ASGCT below:
On Demand: Cell and Gene Therapies – How High Can Prices Go?
Join our experts on April 26, 2023 at 9AM EST as we dive into a powerful 30 minute webinar followed by live Q&A.
This ON24 webinar will discuss how cell and gene therapies can be justifiably priced at different levels. We will explore just how high they can extend and also how we can collectively ensure that patients can access these innovations when they are needed. This discussion will be led by David Carr: Senior Director, Global Pricing and Market Access (PRECISIONadvisors), Richard Macaulay: SVP, Global Pricing and Market Access (PRECISIONadvisors).
Precision Value & Health Acquires Makara Health, Expanding the Company’s Footprint and Communications Capabilities in Europe
Bethesda, Md., April 12, 2023 — Precision Value & Health, the industry leader in delivering complementary, integrated and specialized capabilities across the commercialization continuum, today announced that it has acquired Makara Health, a UK-based international healthcare communications agency. The move will expand Precision’s European footprint and reinforce the company’s market growth position with its core capabilities in Europe. Founded in 2013, Makara has capabilities in learning and development, medical and patient education, PR and brand promotion, offering its diverse roster of healthcare client companies high-quality, strategic, scientifically robust programs, as well as creative delivery solutions.
With this acquisition, Makara becomes part of the Precision Value & Health team. The Makara team will work closely with PRECISIONscientia, an agency dedicated to delivering medical and scientific communications that expertly interpret and translate the science of medicine.